Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
Journal of Neuroimmunology|March 1, 1993
Induction of toxoplasmostasis in a human glioblastoma by interferon gammaW Däubener, K Pilz, S Seghrouchni Zennati, et al.Journal of Pineal Research|March 21, 2023
The impact of daylight-saving time (DST) on patients with delayed sleep-wake phase disorder (DSWPD)Cátia Reis, Luísa K Pilz, Achim Kramer, et al.Scientific Reports|August 1, 2018
Sleep and light exposure across different levels of urbanisation in Brazilian communitiesLuísa K Pilz, Rosa Levandovski, Melissa A B Oliveira, et al.Behavioural Brain Research|March 29, 2001
Increased sensitization of acoustic startle response in spasmodic mice with a mutation of the glycine receptor alpha1-subunit geneC F Plappert, P K Pilz, K Becker, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 20, 2013
Interactive effects of N-acetylcysteine and antidepressantsLuciane Costa-Campos, Ana P Herrmann, Luísa K Pilz, et al.Behavioural Pharmacology|February 14, 2012
AMPA glutamate receptors mediate the antidepressant-like effects of N-acetylcysteine in the mouse tail suspension testViviane M Linck, Luciane Costa-Campos, Luísa K Pilz, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 13, 2020
The impact of selective serotonin reuptake inhibitors on the thyroid function among patients with major depressive disorder: A systematic review and meta-analysisArthur Caye, Luisa K Pilz, Ana L Maia, et al.Frontiers in Physiology|February 14, 2022
Relationship Between Circadian Strain, Light Exposure, and Body Mass Index in Rural and Urban Quilombola CommunitiesDébora Barroggi Constantino, Nicoli Bertuol Xavier, Rosa Levandovski, et al.Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|March 26, 2015
Differential susceptibility of BALB/c, C57BL/6N, and CF1 mice to photoperiod changesLuísa K Pilz, Caroline L Quiles, Eliane Dallegrave, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2015
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumorsF de Braud, S Cascinu, G Spitaleri, et al.Pageof 7